These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35341570)

  • 21. Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics.
    Dasgupta P; Mann A; Polgar WE; Reinscheid RK; Zaveri NT; Schulz S
    Sci Rep; 2022 May; 12(1):7154. PubMed ID: 35504962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.
    Ko MC; Husbands SM
    Handb Exp Pharmacol; 2022; 271():435-452. PubMed ID: 33274403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bifunctional μ opioid and σ
    Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
    Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects.
    Gerak LR; Maguire DR; Cami-Kobeci G; Olson KM; Traynor JR; Husbands SM; France CP; Acevedo L; Belli B; Flynn P
    Behav Pharmacol; 2022 Sep; 33(6):377-394. PubMed ID: 35947066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.
    Smith MT; Kong D; Kuo A; Imam MZ; Williams CM
    J Med Chem; 2023 Mar; 66(6):3746-3784. PubMed ID: 36856340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hot topics in opioid pharmacology: mixed and biased opioids.
    Azzam AAH; McDonald J; Lambert DG
    Br J Anaesth; 2019 Jun; 122(6):e136-e145. PubMed ID: 31010646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.
    Sukhtankar DD; Lee H; Rice KC; Ko MC
    Psychopharmacology (Berl); 2014 Apr; 231(7):1377-87. PubMed ID: 24217900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nociceptin/orphanin FQ receptor and pain: Feasibility of the fourth opioid family member.
    Di Cesare Mannelli L; Micheli L; Ghelardini C
    Eur J Pharmacol; 2015 Nov; 766():151-4. PubMed ID: 26277324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
    Journigan VB; Polgar WE; Khroyan TV; Zaveri NT
    Bioorg Med Chem; 2014 Apr; 22(8):2508-16. PubMed ID: 24657054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
    Guan Q; Velho RV; Sehouli J; Mechsner S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pain Wars: A New Hope.
    Parker KE; Bruchas MR
    Neuron; 2018 Dec; 100(6):1280-1282. PubMed ID: 30571940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-type specific molecular architecture for mu opioid receptor function in pain and addiction circuits.
    Ochandarena NE; Niehaus JK; Tassou A; Scherrer G
    Neuropharmacology; 2023 Nov; 238():109597. PubMed ID: 37271281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors.
    Gerak LR; Maguire DR; France CP
    Handb Exp Pharmacol; 2020; 258():127-145. PubMed ID: 31451969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.
    Webster L; Schmidt WK
    Pain Med; 2020 May; 21(5):992-1004. PubMed ID: 31165885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile.
    Dietis N; Guerrini R; Calo G; Salvadori S; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2009 Jul; 103(1):38-49. PubMed ID: 19474215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid MOP receptor agonists in late-stage development for the treatment of postoperative pain.
    Qiu Q; Chew JC; Irwin MG
    Expert Opin Pharmacother; 2022 Nov; 23(16):1831-1843. PubMed ID: 36302462
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.